Gene: Set-ps15 (Set nuclear proto-oncogene, pseudogene 15) Rattus norvegicus
Analyze
Symbol:
Set-ps15
Name:
Set nuclear proto-oncogene, pseudogene 15
RGD ID:
1585864
Description:
Type:
pseudo
RefSeq Status:
MODEL
Previously known as:
LOC680925; similar to SET protein (Phosphatase 2A inhibitor I2PP2A) (I-2PP2A) (Template-activating factor I) (TAF-I) (Liver regeneration-related protein LRRGR00002)
Latest Assembly:
mRatBN7.2 - mRatBN7.2 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 14 8,821,697 - 8,823,933 (+) NCBI GRCr8 mRatBN7.2 14 8,517,301 - 8,519,537 (+) NCBI mRatBN7.2 mRatBN7.2 Rnor_6.0 14 10,112,888 - 10,123,723 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_5.0 14 10,066,520 - 10,074,268 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 14 9,774,309 - 9,797,880 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 14 8,628,709 - 8,635,295 (+) NCBI Celera Cytogenetic Map 14 p22 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
References
Genomics
QTLs in Region (mRatBN7.2)
2300159 Bmd61 Bone mineral density QTL 61 5.3 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 14 1 26541967 Rat 2300183 Bmd60 Bone mineral density QTL 60 5.7 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 14 1 26541967 Rat 619619 Rf4 Renal disease susceptibility QTL 4 4.1 0.002 urine total protein amount (VT:0000032) urine protein excretion rate to body weight ratio (CMO:0001099) 14 1 32754612 Rat 634352 Apr6 Acute phase response QTL 6 3.7 blood interleukin-6 amount (VT:0008595) plasma interleukin-6 level (CMO:0001927) 14 1 41131407 Rat 71115 Niddm15 Non-insulin dependent diabetes mellitus QTL 15 4.8 blood glucose amount (VT:0000188) plasma glucose level (CMO:0000042) 14 1217606 11030812 Rat 70204 Niddm20 Non-insulin dependent diabetes mellitus QTL 20 5.1 0.000008 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 14 1217606 16960180 Rat 724541 Niddm53 Non-insulin dependent diabetes mellitus QTL 53 0.001 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 14 3813074 9088978 Rat 2293089 Iddm31 Insulin dependent diabetes mellitus QTL 31 4.7 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 14 3813074 18274691 Rat 2293089 Iddm31 Insulin dependent diabetes mellitus QTL 31 4.7 blood glucose amount (VT:0000188) age at onset/diagnosis of type 1 diabetes mellitus (CMO:0001140) 14 3813074 18274691 Rat 1300114 Srn2 Serum renin concentration QTL 2 3.27 blood renin amount (VT:0003349) plasma renin activity level (CMO:0000116) 14 3813074 21217635 Rat 70195 Mcs8 Mammary carcinoma susceptibility QTL 8 4.28 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 14 3813074 24531477 Rat 1331740 Bw26 Body weight QTL 26 3.028 body mass (VT:0001259) body weight (CMO:0000012) 14 3813074 30767156 Rat 1581500 Renag1 Renal agenesis QTL 1 kidney development trait (VT:0000527) percentage of study population developing unilateral renal agenesis during a period of time (CMO:0000940) 14 8170668 68298175 Rat 1358296 Ael3 Aortic elastin QTL 3 3.7 0.00051 aorta elastin amount (VT:0003905) aortic elastin 14 8267090 53267090 Rat 2302045 Pia39 Pristane induced arthritis QTL 39 4.9 0.001 blood immunoglobulin amount (VT:0002460) serum immunoglobulin G2a level (CMO:0002116) 14 8267090 53267090 Rat
Markers in Region
D14Rat73
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 14 8,544,312 - 8,544,522 (+) MAPPER mRatBN7.2 Rnor_6.0 14 10,147,879 - 10,148,088 NCBI Rnor6.0 Rnor_5.0 14 10,101,599 - 10,101,808 UniSTS Rnor5.0 RGSC_v3.4 14 9,826,035 - 9,826,245 RGD RGSC3.4 RGSC_v3.4 14 9,826,036 - 9,826,245 UniSTS RGSC3.4 RGSC_v3.1 14 9,825,808 - 9,826,249 RGD Celera 14 8,655,723 - 8,655,928 UniSTS RH 2.0 Map 3 515.2 RGD SHRSP x BN Map 14 4.62 RGD Cytogenetic Map 14 p22 UniSTS
Expression
Sequence
Additional Information
Nomenclature History
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2022-06-23
Set-ps15
Set nuclear proto-oncogene, pseudogene 15
SET-ps15
SET nuclear proto-oncogene, pseudogene 15
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2022-06-10
SET-ps15
SET nuclear proto-oncogene, pseudogene 15
LOC680925
similar to SET protein (Phosphatase 2A inhibitor I2PP2A) (I-2PP2A) (Template-activating factor I) (TAF-I) (Liver regeneration-related protein LRRGR00002)
Symbol and Name Changed
1299863
APPROVED
2006-11-19
LOC680925
similar to SET protein (Phosphatase 2A inhibitor I2PP2A) (I-2PP2A) (Template-activating factor I) (TAF-I) (Liver regeneration-related protein LRRGR00002)
Symbol and Name status set to provisional
70820
PROVISIONAL